New lupus drug shows promise in major trial
NCT ID NCT05624749
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This phase 3 study tests whether adding a monthly injection of ianalumab to standard lupus treatments helps control active disease better than placebo. About 288 people aged 12 and older with systemic lupus erythematosus (SLE) are taking part. The main goal is to see if ianalumab reduces lupus activity without causing serious flares. This is not a cure, but aims to improve disease control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Accurate Clinical Research
Lake Charles, Louisiana, 70601, United States
-
Advanced Medical Research
La Palma, California, 90623, United States
-
Ahmed Arif Medical Research Center
Grand Blanc, Michigan, 48439, United States
-
Bluegrass Community Research Inc
Lexington, Kentucky, 40504, United States
-
Emory University
Atlanta, Georgia, 30307, United States
-
Homestead Assoc In Research Inc
Homestead, Florida, 33033, United States
-
IRIS Research and Development
Plantation, Florida, 33324, United States
-
Novartis Investigative Site
La Plata, Buenos Aires, B1900AWT, Argentina
-
Novartis Investigative Site
Quilmes, Buenos Aires, 1878, Argentina
-
Novartis Investigative Site
San Miguel, Buenos Aires, B1663GKT, Argentina
-
Novartis Investigative Site
San Miguel, Tucumán Province, T4000CBC, Argentina
-
Novartis Investigative Site
Caba, C1015ABO, Argentina
-
Novartis Investigative Site
Caba, C1427CCL, Argentina
-
Novartis Investigative Site
San Miguel de Tucumán, T4000AXL, Argentina
-
Novartis Investigative Site
Maroochydore, Queensland, 4558, Australia
-
Novartis Investigative Site
St Leonards, 2065, Australia
-
Novartis Investigative Site
Concepción, Biobio, 4070280, Chile
-
Novartis Investigative Site
Valdivia, Los Ríos Region, 5110683, Chile
-
Novartis Investigative Site
Santiago, RM, 7500588, Chile
-
Novartis Investigative Site
Santiago, Santiago Metropolitan, 7500710, Chile
-
Novartis Investigative Site
Medellín, Antioquia, 050001, Colombia
-
Novartis Investigative Site
Barranquilla, Atlántico, 080002, Colombia
-
Novartis Investigative Site
Barranquilla, Atlántico, 080020, Colombia
-
Novartis Investigative Site
Chía, Cundinamarca, 250001, Colombia
-
Novartis Investigative Site
Bucaramanga, Santander Department, 680003, Colombia
-
Novartis Investigative Site
Cali, Valle del Cauca Department, 760046, Colombia
-
Novartis Investigative Site
Bogotá, 111211, Colombia
-
Novartis Investigative Site
Montpellier, 34295, France
-
Novartis Investigative Site
Paris, 75013, France
-
Novartis Investigative Site
Paris, 75014, France
-
Novartis Investigative Site
Paris, 75018, France
-
Novartis Investigative Site
Toulouse, 31054, France
-
Novartis Investigative Site
Toulouse, 31059, France
-
Novartis Investigative Site
Tours, 37044, France
-
Novartis Investigative Site
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
Novartis Investigative Site
Cologne, North Rhine-Westphalia, 50937, Germany
-
Novartis Investigative Site
Leipzig, Saxony, 04103, Germany
-
Novartis Investigative Site
Herne, 44649, Germany
-
Novartis Investigative Site
Mainz, 55131, Germany
-
Novartis Investigative Site
Ahmedabad, Gujarat, 380006, India
-
Novartis Investigative Site
Ahmedabad, Gujarat, 380015, India
-
Novartis Investigative Site
Kozhikode, Kerala, 673008, India
-
Novartis Investigative Site
Kolhāpur, Maharashtra, 416001, India
-
Novartis Investigative Site
Nagpur, Maharashtra, 441108, India
-
Novartis Investigative Site
Nashik, Maharashtra, 422101, India
-
Novartis Investigative Site
Pune, Maharashtra, 411001, India
-
Novartis Investigative Site
Pune, Maharashtra, 411007, India
-
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, 110060, India
-
Novartis Investigative Site
New Delhi, New Delhi, 110029, India
-
Novartis Investigative Site
Dehradun, Uttarakhand, 248001, India
-
Novartis Investigative Site
New Delhi, 110075, India
-
Novartis Investigative Site
Ancona, AN, 60020, Italy
-
Novartis Investigative Site
Cona, FE, 44124, Italy
-
Novartis Investigative Site
Padova, PD, 35128, Italy
-
Novartis Investigative Site
Pisa, PI, 56126, Italy
-
Novartis Investigative Site
Roma, RM, 00152, Italy
-
Novartis Investigative Site
Torino, TO, 10128, Italy
-
Novartis Investigative Site
Seremban, Negeri Sembilan, 70300, Malaysia
-
Novartis Investigative Site
Ipoh, Perak, 30450, Malaysia
-
Novartis Investigative Site
Kuala Lumpur, 59100, Malaysia
-
Novartis Investigative Site
Selangor Darul Ehsan, 68100, Malaysia
-
Novartis Investigative Site
León, Guanajuato, 37160, Mexico
-
Novartis Investigative Site
Guadalajara, Jalisco, 44160, Mexico
-
Novartis Investigative Site
Mexico City, Mexico City, 06700, Mexico
-
Novartis Investigative Site
Morelia, Michoacán, 58000, Mexico
-
Novartis Investigative Site
Mérida, Yucatán, 97000, Mexico
-
Novartis Investigative Site
Mérida, Yucatán, 97070, Mexico
-
Novartis Investigative Site
México, 07760, Mexico
-
Novartis Investigative Site
Cluj-Napoca, Cluj, 400006, Romania
-
Novartis Investigative Site
Brasov, 500283, Romania
-
Novartis Investigative Site
Bucharest, 011172, Romania
-
Novartis Investigative Site
Gwangju Gwangyeoksi, Gwangju, 61748, South Korea
-
Novartis Investigative Site
Seoul, 04763, South Korea
-
Novartis Investigative Site
Seoul, 06591, South Korea
-
Novartis Investigative Site
Kaohsiung City, 833, Taiwan
-
Novartis Investigative Site
Taichung, 40447, Taiwan
-
Novartis Investigative Site
Taichung, 407219, Taiwan
-
Novartis Investigative Site
Taipei, 10002, Taiwan
-
Novartis Investigative Site
Taipei, 11217, Taiwan
-
Novartis Investigative Site
Taoyuan, 33305, Taiwan
-
Novartis Investigative Site
Leeds, West Yorkshire, LS7 4SA, United Kingdom
-
Novartis Investigative Site
Doncaster, DN2 5LT, United Kingdom
-
Novel Research LLC
Bellaire, Texas, 77401, United States
-
Pinnacle Research Group LLC
Anniston, Alabama, 36207-5710, United States
-
UMC New Orleans
New Orleans, Louisiana, 70112, United States
-
University Of Maryland
Baltimore, Maryland, 21201, United States
-
University of California LA
Los Angeles, California, 90095, United States
-
Washington Univ School Of Medicine
St Louis, Missouri, 63110, United States
-
West Tennessee Research Institute
Jackson, Tennessee, 38305, United States
-
Willow Rheumatology Wellness
Willowbrook, Illinois, 60527, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Could a single injection tame lupus and Sjögren's?
- Can a single infusion tame tough lupus?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
- Can genetics and environment explain lupus in the gullah population?
- Can a smartphone app bridge the lupus care gap for women of color?